Cytomegalovirus (CMV) (cont.)

Medical Author:
Medical Editor:

How do physicians diagnose cytomegalovirus infection?

Most CMV infections go undiagnosed because the virus causes little to no symptoms. When a person is infected with CMV, antibodies (proteins) to the virus called IgG develop and stay in the body for the rest of the person's life. A blood test to detect the antibodies will be positive if the person has had a CMV infection.

During an active infection, the virus can be found in bodily fluids or body tissues by culturing (growing) the virus or detecting its DNA or specific protein called pp65 antigen.

A physician may diagnose a congenital CMV infection if he or she detects the virus in a newborn's urine, saliva, blood, or other body tissues within two to three weeks after birth.

What is the treatment for cytomegalovirus infection?

Comment on this

There is no cure for CMV, and treatment for CMV infection is not necessary in healthy children and adults. People with a weakened immune system who have symptoms of CMV infection are placed on antiviral medication. Up to 75% of transplant recipients develop CMV infection. Those who have at a very high risk of developing severe CMV infection may be placed on antiviral medication to prevent CMV disease. This pretreatment is called prophylaxis. This method has helped reduce the number of CMV infection in these patients. The antiviral medications against CMV include the following:

  • Ganciclovir (Cytovene) is the first antiviral medication approved for the treatment of CMV infection. Ganciclovir, given intravenously, is the drug of choice for the treatment of CMV infection. Side effects include fever, rash, diarrhea, anemia, and low white blood cell and platelet counts.
  • Valganciclovir (Valcyte) is an oral medication that is activated to ganciclovir in the body and widely used to prevent CMV infection (prophylaxis). It is used in selected patients for the treatment of CMV infection and is as effective as intravenous ganciclovir in non-severe cases.
  • Foscarnet (Foscavir) is active against CMV by a different mechanism than ganciclovir and used to treat infections with CMV that are resistant to ganciclovir. It is a second-line therapy for patients who do not tolerate ganciclovir treatment. Foscarnet is toxic to the kidneys and can cause seizures due to an imbalance of minerals and electrolytes.
  • Cidofovir (Vistide) is an alternative therapy for patients who have failed ganciclovir and foscarnet treatment. Its use is limited due to toxicity to the kidneys. It is used mainly for the treatment of CMV infection of the eye (retinitis) in patients with acquired immune deficiency syndrome (AIDS) caused by the human immunodeficiency virus (HIV).
  • CMV immune globulin contains antibodies (proteins) that are specific to CMV. It is FDA-approved to prevent CMV infection in high-risk lung transplant patients when given in addition to ganciclovir. It is also used with ganciclovir to treat CMV pneumonia.

No antiviral drug is FDA-approved for the treatment of congenital CMV infection. However, some infants who have infection involving the central nervous system (brain and spinal cord) may benefit from treatment. Some evidence shows that ganciclovir may prevent hearing loss and development problems in infants who have severe symptoms of congenital CMV infection. Because of the serious side effects of ganciclovir, a physician specialist should be consulted.

Medically Reviewed by a Doctor on 4/3/2014

Patient Comments

Viewers share their comments

Cytomegalovirus (CMV) Infection - Symptoms Question: What symptoms and signs did you experience with CMV?
Cytomegalovirus (CMV) Infection - Prevention Question: Please share tips and suggestions for preventing CMV.
Cytomegalovirus - HIV Question: If you have HIV, please share your experience with CMV.
Cytomegalovirus (CMV) Infection - Treatment Question: What treatment was effective for your CMV?

STAY INFORMED

Get the Latest health and medical information delivered direct to your inbox!